quinoxalines and bay-k-8644

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Calcium; Dogs; Dose-Response Relationship, Drug; Endothelins; Female; In Vitro Techniques; Male; Mesenteric Arteries; Mesenteric Veins; Potassium Chloride; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzofurans; Calcium; Cell Survival; Cells, Cultured; Electrophysiology; Fluorescent Dyes; Fura-2; Glycine; Hippocampus; Magnesium; Neurons; Nimodipine; Pyramidal Tracts; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synapses

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Azepines; Blood Pressure; Brimonidine Tartrate; Cardiac Output; Cats; Dinoprost; Dioxanes; Electric Stimulation; Female; Idazoxan; Male; Methoxamine; Nifedipine; Nisoldipine; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Quinoxalines; Splanchnic Circulation; Sulfonamides; Sympathetic Nervous System; Tyramine; Vascular Resistance; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Calcium Channel Agonists; Dose-Response Relationship, Drug; Enzyme Activation; Genistein; Isoflavones; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Pertussis Toxin; Phospholipase D; Potassium; Protein-Tyrosine Kinases; Quinoxalines; Rats; Receptors, Adrenergic, alpha; Virulence Factors, Bordetella

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antineoplastic Agents; Benzazepines; Calcium Channel Agonists; Calcium Channel Blockers; Colon; Cyclic GMP; Dopamine Antagonists; Enzyme Inhibitors; Hexamethonium; Imines; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Nitric Oxide; Nitroarginine; omega-Conotoxins; Oxadiazoles; Peristalsis; Quinoxalines; Rats; Rats, Sprague-Dawley; Suramin; Tetrodotoxin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Brimonidine Tartrate; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Enzyme Inhibitors; Hypertension; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide Synthase; Nitroarginine; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Colon; Dogs; Electric Conductivity; Enteric Nervous System; Enzyme Inhibitors; Female; Gastrointestinal Motility; In Vitro Techniques; Indoles; Male; Membrane Potentials; Mitochondria; Muscle, Smooth; Nickel; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroarginine; Nitroprusside; Oxadiazoles; Potassium; Quinoxalines; Uncoupling Agents

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Cadmium; Calcium Channel Blockers; Calcium Channels, L-Type; Egtazic Acid; In Vitro Techniques; Kinetics; Male; Neurotransmitter Agents; Nifedipine; Quinoxalines; Rats; Rats, Sprague-Dawley; Thapsigargin

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium; Calcium Channel Agonists; Enzyme Inhibitors; HeLa Cells; Humans; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Pulmonary Artery; Pulmonary Veins; Quinolizines; Quinoxalines; Receptors, Adrenergic, alpha-2; Swine; Vasoconstriction

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Animals; Arteries; Calcium; Calcium Channel Agonists; Calcium Channels; Endothelium, Vascular; Guanylate Cyclase; Ions; Male; Muscle Contraction; Nitric Oxide Synthase; Nitroarginine; Oxadiazoles; Potassium Chloride; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Benzothiadiazines; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Dipeptides; Excitatory Postsynaptic Potentials; Female; Gerbillinae; Hair Cells, Vestibular; Male; Nifedipine; Quinoxalines; Receptors, AMPA; Strontium; Synapses